David L. Rosen, a partner and co-chair of the Life Sciences Industry Team of Foley & Lardner LLP will participate in presenting the Webcast, “Introduction to Drug and Medical Device Law” hosted by the The Regulatory Affairs Professionals Society. This course will provide an overview of how drugs and medical devices are regulated in the United States. Attendees will specifically:
- Learn the basics concerning the laws and regulations that impact the pharmaceutical industry
- Gain an understanding of the different statutory provisions and how they operate in reality
- Get a sense of FDA’s organization, the history of drug regulation, and how new drugs, generic drugs and over-the-counter (OTC) drugs get into the marketplace
- Learn the basics concerning the laws and regulations that impact the medical device industry
- Get a sense of FDA’s organization, the history of medical device regulation and how new medical devices and substantially equivalent medical devices get in the market place and the post market requirements
- Gain an overview of the Quality System Regulation (QSR), adverse events, and promotion and advertising
People
Related Insights
January 13, 2026
Foley Viewpoints
Recent IRS Guidance on Branch Profits Tax Treaty Benefits for Foreign Reverse Hybrid Entities
The IRS recently issued a Chief Counsel Advice Memorandum (AM 2025-002) (the CCA) that provides helpful guidance regarding the application of the branch profits tax (BPT) in connection with reverse foreign hybrid (RFH) entities and U.S. income tax treaties with foreign countries.
January 13, 2026
Foley Career Perspectives
Foley Attorneys Deepen Boys & Girls Clubs of America Partnership
As the first and only law firm to partner with BGCA on a national scale, Foley supports the organization's youth leadership development strategy through programs and initiatives that open doors for the next generation to thrive.
January 12, 2026
Energy Current
Ninth Circuit Hears Oral Argument in Challenge to California Climate Disclosure Laws SB 261 and SB 253; No Ruling Yet
On January 9, 2026, a three-judge panel for the U.S. Court of Appeals for the Ninth Circuit heard oral argument in a challenge to…